Cargando…
Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational Study
Although COVID-19 is associated with high von Willebrand factor (vWF) parameters promoting thrombosis, venovenous extracorporeal membrane oxygenation (vvECMO) is associated with the development of acquired von Willebrand syndrome (AVWS) promoting bleeding. This study was designed to assess both the...
Autores principales: | Kalbhenn, Johannes, Glonnegger, Hannah, Büchsel, Martin, Priebe, Hans-Joachim, Zieger, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275806/ https://www.ncbi.nlm.nih.gov/pubmed/35234414 http://dx.doi.org/10.1097/CCM.0000000000005467 |
Ejemplares similares
-
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
por: Büchsel, Martin, et al.
Publicado: (2023) -
Different mechanisms of oxygenator failure and high plasma von Willebrand factor antigen influence success and survival of venovenous extracorporeal membrane oxygenation
por: Steiger, Tamara, et al.
Publicado: (2021) -
Desmopressin testing in von Willebrand disease: Lowering the burden
por: Heijdra, Jessica M., et al.
Publicado: (2022) -
Impact of intraoperative use of venovenous extracorporeal membrane oxygenation on the status of von Willebrand factor large multimers during single lung transplantation
por: Oishi, Hisashi, et al.
Publicado: (2023) -
Desmopressin responsiveness by age in type 1 von Willebrand disease
por: Goldberg, Nicola, et al.
Publicado: (2020)